CRC: Emerging Immunotherapy Strategies in MSS Tumors – OncLive
OncLive |
CRC: Emerging Immunotherapy Strategies in MSS Tumors
OncLive Panelists: John L. Marshall, MD, Georgetown University Hospital; Dirk Arnold, MD, PhD, Instituto CUF de Oncologia; University of Hamburg; Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli; Paul R. Helft, MD, Indiana School of Medicine of the … |
Markets Insider |
Next-gen gene editor will be the CRISPR sequel we’ve been waiting for
Digital Trends Just when we were getting used to the CRISPR/Cas9 gene editing revolution, a new “fourth-generation” DNA base editor has come along — offering a new way to modify the genetic code that may be safer in terms of reducing potential mistakes. Base editing … University of South Carolina to provide Transomic Technologies’ CRISPR-Cas9 products through its Viral Vector CoreMarkets Insider How Gene Editing Might Reshape Diabetes TreatmentA Sweet Life |